We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Metabolomic analysis of healthy human urine following administration of glimepiride using a liquid chromatography-tandem mass spectrometry.
- Authors
Eun Young Do; Mi-Ri Gwon; Bo Kyung Kim; Boram Ohk; Hae Won Lee; Woo Youl Kang; Sook Jin Seong; Hyun-Ju Kim; Young-Ran Yoon
- Abstract
Glimepiride, a third generation sulfonylurea, is an antihyperglycemic agent widely used to treat type 2 diabetes mellitus. In this study, an untargeted urinary metabolomic analysis was performed to identify endogenous metabolites affected by glimepiride administration. Urine samples of twelve healthy male volunteers were collected before and after administration of 2 mg glimepiride. These samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and then subjected to multivariate data analysis including principal component analysis and orthogonal partial least squares discriminant analysis. Through this metabolomic profiling, we identified several endogenous metabolites such as adenosine 3', 5'-cyclic monophosphate (cAMP), quercetin, tyramine, and urocanic acid, which exhibit significant metabolomic changes between pre- and posturine samples. Among these, cAMP, which is known to be related to insulin secretion, was the most significantly altered metabolite following glimepiride administration. In addition, the pathway analysis showed that purine, tyrosine, and histidine metabolism was affected by pharmacological responses to glimepiride. Together, the results suggest that the pharmacometabolomic approach, based on LC-MS/MS, is useful in understanding the alterations in biochemical pathways associated with glimepiride action.
- Subjects
LIQUID chromatography-mass spectrometry; TYPE 2 diabetes treatment; METABOLIC profile tests
- Publication
Translational & Clinical Pharmacology, 2017, Vol 25, Issue 2, p67
- ISSN
2289-0882
- Publication type
Article
- DOI
10.12793/tcp.2017.25.2.67